Search results for "Renin-Angiotensin"

showing 6 items of 46 documents

Genetic bases of urinary albumin excretion and related traits in hypertension

2010

Epidemiological as well as animal studies have recognized the potential role of genetic factors in the development of microalbuminuria and related traits (renal insufficiency, end-stage renal disease and nephroangiosclerosis) in hypertension. To unravel genetic variants of susceptibility, candidate gene, linkage and genome wide scan analysis has been used. In spite of the great efforts that have been made in the field, sound knowledge about the major genetic variants causing the susceptibility to develop renal damage in hypertension is scarce, since many associations were not replicated or only showed association in a certain subgroup of patients. Looking initially at genes of the most impo…

medicine.medical_specialtyCandidate geneGenetic LinkagePhysiologyGenome-wide association studyDiseaseBioinformaticsGenomeRenin-Angiotensin SystemGenetic linkageInternal medicineInternal MedicinemedicineAlbuminuriaAnimalsHumansGenetic Predisposition to DiseaseNatriuretic PeptidesGenebusiness.industrymedicine.diseaseReceptors AdrenergicOxidative StressEndocrinologyHypertensionAlbuminuriaKallikreinsMicroalbuminuriamedicine.symptomCardiology and Cardiovascular MedicinebusinessGenome-Wide Association StudyJournal of Hypertension
researchProduct

Alcohol puts the heart under pressure: Acetaldehyde activates a localized renin angiotensin aldosterone system within the myocardium in alcoholic car…

2018

medicine.medical_specialtyCardiomyopathyAlcoholBlood PressureAcetaldehyde030204 cardiovascular system & hematologyAlcoholic cardiomyopathyRenin-Angiotensin System03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineRenin–angiotensin systemReninmedicineHumans030212 general & internal medicineEthanolEthanolbusiness.industryAngiotensin IICardiomyopathy AlcoholicMyocardiumAcetaldehydemedicine.diseaseAngiotensin IIEndocrinologyBlood pressurechemistryCardiology and Cardiovascular MedicinebusinessInternational journal of cardiology
researchProduct

The Role of Endothelium in COVID-19

2021

The 2019 novel coronavirus, known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), is causing a global pandemic. The virus primarily affects the upper and lower respiratory tracts and raises the risk of a variety of non-pulmonary consequences, the most severe and possibly fatal of which are cardiovascular problems. Data show that almost one-third of the patients with a moderate or severe form of COVID-19 had preexisting cardiovascular comorbidities such as diabetes mellitus, obesity, hypertension, heart failure, or coronary artery disease. SARS-CoV2 causes hyper inflammation, hypoxia, apoptosis, and a renin–angiotensin system imbalance …

medicine.medical_specialtyComplications Endothelium Pathogenesis COVID-19 Cytokine Release Syndrome Endothelial Cells Heart Failure Humans Renal Insufficiency Renin-Angiotensin System SARS-CoV-2 ThrombosisEndotheliumendotheliumcomplicationsQH301-705.5InflammationReviewCatalysisRenin-Angiotensin SystemInorganic ChemistryCoronary artery diseasePathogenesisInternal medicineDiabetes mellitusHumansMedicineRenal InsufficiencyBiology (General)Physical and Theoretical ChemistryEndothelial dysfunctionQD1-999Molecular BiologySpectroscopyHeart Failurebusiness.industrySARS-CoV-2pathogenesisOrganic ChemistryEndothelial CellsCOVID-19ThrombosisGeneral MedicineHypoxia (medical)medicine.diseaseComputer Science ApplicationsChemistrymedicine.anatomical_structureHeart failureCardiologymedicine.symptomCytokine Release SyndromebusinessInternational Journal of Molecular Sciences
researchProduct

Mechanisms of hypertension in the cardiometabolic syndrome

2009

Arterial hypertension is often part of a constellation of anthropometric and metabolic abnormalities that occur simultaneously to a higher degree than would be expected by chance alone, supporting the existence of a discrete disorder, the so-called metabolic syndrome. It is the result of interactions among a large number of interconnected mechanisms, which eventually lead to both an increase in cardiovascular and renal risk, and the development of diabetes. Mechanisms involved in the metabolic syndrome are obesity, insulin resistance, and a constellation of independent factors, which include molecules of hepatic, vascular, and immunologic origin with pro-inflammatory properties. At each of …

medicine.medical_specialtyEndotheliumPhysiologymedicine.medical_treatmentAdipose tissueRenin-Angiotensin SystemInsulin resistanceInternal medicineDiabetes mellitusInternal MedicinemedicineHumansObesityEndothelial dysfunctionAbdominal obesityMetabolic Syndromebusiness.industryInsulinSyndromemedicine.diseasemedicine.anatomical_structureEndocrinologyCardiovascular DiseasesHypertensionBlood VesselsEndothelium VascularMED/09 - MEDICINA INTERNAInsulin ResistanceMetabolic syndromemedicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of Hypertension
researchProduct

The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS

2008

Atrial fibrillation (AF) is the most common rhythm disturbance in medical practice and represents a very expensive health problem. AF can be managed with the prevention of thromboembolism and either a rate control of rhythm strategy. As both strategies have important limitations, probably a preventative strategy in patients at risk of developing arrhythmia can be a more attractive option. The renin-angiotensin system (RAS) seems to be involved in the genesis of arrhythmia by the following two mechanisms: 1. the induction of atrial fibrosis and structural remodelling by mitogen-activated protein kinase (MAPK) expression and reduction of collagenase activity; 2. the induction of electrical re…

medicine.medical_specialtyHeart diseaseGenotypeElectric CountershockAngiotensin-Converting Enzyme InhibitorsReview ArticleRenin-Angiotensin Systemrenin-angiotensin system atrial fibrillation ACE-I ARBDiabetes mellitusInternal medicineRenin–angiotensin systemAtrial FibrillationmedicineHumansPharmacology (medical)PharmacologyMitogen-Activated Protein Kinase KinasesEvidence-Based Medicinebiologybusiness.industryAngiotensin IIfungifood and beveragesAtrial fibrillationAngiotensin-converting enzymemedicine.diseaseAngiotensin IIEndocrinologyHeart failureACE inhibitorCardiologybiology.proteinbusinessAnti-Arrhythmia Agentsmedicine.drug
researchProduct

Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection

2020

To determine the effect renin-angiotensin system blockers on the outcome in patients with hypertension and concurrent COVID-19 infection, we searched PubMed, the Cochrane Library, and Google Scholar for relevant articles. Twelve studies with a total of 16,101 patients met the inclusion criteria. The mortality rate among the users of angiotensin converting enzyme inhibitors or angiotensin receptor blockers was 12.15% and in non-users it was 14.56% (risk ratio 0.70, 95% CI [0.53-0.91], P < 0.007). There was no difference in the risk of death between the use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers (risk ratio 1.09, 95% CI [0.90 -1.32]). We conclude tha…

medicine.medical_specialtyhypertensionCoronavirus disease 2019 (COVID-19)PopulationPneumonia ViralAngiotensin-Converting Enzyme Inhibitors030204 cardiovascular system & hematologyCochrane LibraryGastroenterologyArticleRenin-Angiotensin System03 medical and health sciencesAngiotensin Receptor AntagonistsBetacoronavirus0302 clinical medicineInternal medicineRenin–angiotensin systemmedicineHumansPharmacology (medical)In patient030212 general & internal medicineeducationPandemicsPharmacologyeducation.field_of_studybiologybusiness.industrySARS-CoV-2Mortality rateCOVID-19Angiotensin-converting enzymerenin-angiotensin-aldosterone systemRelative riskbiology.proteinCardiology and Cardiovascular MedicinebusinessCoronavirus InfectionsAngiotensin II Type 1 Receptor BlockersJournal of Cardiovascular Pharmacology and Therapeutics
researchProduct